The Impact of Glycolipid Metabolic Disorders on Severity Stage-Specific Variation of Cardiac Autonomic Function in Obstructive Sleep Apnea: A Data-Driven Clinical Study
Xiaolong Zhao,Huajun Xu,Chuan Dong,Jiangang Fan,Gang He,Jianyin Zou,Lili Meng,Huaming Zhu,Kaiming Su,Mingpo Yang,Hongliang Yi,Jian Wang,Shankai Yin,Jian Guan
DOI: https://doi.org/10.2147/NSS.S317201
2021-07-28
Nature and Science of Sleep
Abstract:Xiaolong Zhao, 1– 3, &ast Huajun Xu, 1, 3, &ast Chuan Dong, 2, &ast Jiangang Fan, 2 Gang He, 2 Jianyin Zou, 1, 3 Lili Meng, 1, 3 Huaming Zhu, 1, 3 Kaiming Su, 1, 3 Mingpo Yang, 4 Hongliang Yi, 1, 3 Jian Wang, 5 Shankai Yin, 1, 3 Jian Guan 1, 3 1 Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China; 2 Department of Otolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China; 3 Shanghai Key Laboratory of Sleep Disordered Breathing, Shanghai, People's Republic of China; 4 Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China; 5 School of Communication Science and Disorders/Physiol & Biophysics, Dalhousie University, Halifax, NS, Canada &astThese authors contributed equally to this work Correspondence: Shankai Yin; Jian Guan Email ; Background: Cardiac autonomic dysfunction (CAD) is a common pathology in cardiovascular diseases; however, the role of glycolipid metabolic disorders in CAD development in obstructive sleep apnea (OSA) remains poorly understood. Methods: In total, 4152 patients with suspected OSA were recruited in our sleep center. Metabolic characteristics including anthropometric and glycolipid data were collected. Heart rate variability (HRV) was measured to assess the risk of CAD; its dose–response relationship with OSA severity was evaluated via restricted cubic spline (RCS) analysis. A segmented multivariate linear regression (SMLR) model was used to evaluate the roles of metabolic variables in different stages of OSA. Results: The RCS showed that CAD risk increased in a nonlinear relationship pattern with OSA severity, from slow fluctuation at earlier stages to rapid change in later stages. After integrating the clinical definition and RCS selected knots, we obtained the new four OSA severity stages. SMLR model showed that the overall value of glycolipid variables for prediction of HRV abnormalities was greater than the value of OSA variables at earlier stages, while OSA variables were more effective predictors in more severe stages. The discordance in respective relationship of HRV with metabolic and OSA variables sheds the light how metabolic disorders promoted the development of CAD in OSA, the later further in turn deteriorates cardiac function. Conclusion: These results are indicative of stage-specific involvement of glycolipid metabolic factors underlying CAD nonlinear changes in patients with OSA. Early control glycolipid disorders may help the control of CAD development in patients with OSA. Keywords: obstructive sleep apnea, autonomic nervous system, cardiac autonomic neuropathy, metabolism, heart rate variability Obstructive sleep apnea (OSA) is a breathing disorder characterized by recurrent episodes of upper airway collapse during sleep, leading to chronic intermittent hypoxia and sleep fragmentation. 1 Several large cohort studies (eg, the Sleep Heart Health Study and WISCONSIN Study) have shown that OSA is associated with the development of cardiovascular disease (CVD). 2–4 Cardiac autonomic dysfunction (CAD) is a common pathology involved in the development of many CVDs, including arrhythmia, hypertension and coronary artery disease. 5 , 6 In the study of CAD, heart rate variability (HRV) is a widely used, noninvasive measure for assessment of cardiac autonomic function; it is also a good indicator of early impairment of heart function in the development of CVD. 7 , 8 Previous studies have demonstrated that, in patients with OSA, HRV is regulated by multiple sleep-related factors (eg, arousal and sleep quality), as well as breathing-related factors (eg, respiratory rhythm and intrathoracic pressure). 9 , 10 In parallel, multiple glycolipid metabolic disorders (eg, diabetes, hyperlipidemia, and obesity) frequently coexist in patients with OSA and appear to play a causative role in the development of many CVDs; 11 they have been shown to exert significant adverse effects on -Abstract Truncated-
neurosciences,clinical neurology